Prescribing information



Dr Yassir Javaid, GPwER in cardiology, presents a case study of a patient with HFrEF, and discusses their symptoms and how they could have been medically optimised sooner.


Indication: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1

GPwER, GP with extended role;  HFrEF, heart failure with reduced ejection fraction.



  1. Entresto Summary of Product Characteristics, 2020. 
Rate this content: 
No votes yet
ENT20-C046j(1) July 2020.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]